Multicentre Randomised Controlled Trial to Improve the Management of Exacerbations in Children with Bronchiectasis

Project Details

Status	Finished
Effective start/end date	1/01/12 → 31/12/16

Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
Goyal, V., Grimwood, K., Ware, R. S., Byrnes, C. A., Morris, P. S., Masters, I. B., McCallum, G. B., Binks, M. J., Smith-Vaughan, H., O'Grady, K. A. F., Champion, A., Buntain, H. M., Schultz, A., Chatfield, M., Torzillo, P. J. & Chang, A. B., 1 Sep 2019, In : The Lancet Respiratory Medicine. 7, 9, p. 791-801 11 p.
Research output: Contribution to journal › Article
8 Citations (Scopus)